A new trading day began on Monday, with Tango Therapeutics Inc (NASDAQ: TNGX) stock price down -8.21% from the previous day of trading, before settling in for the closing price of $2.07. TNGX’s price has ranged from $1.97 to $12.02 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 103.26%. Meanwhile, its annual earnings per share averaged -12.98%. With a float of $59.12 million, this company’s outstanding shares have now reached $107.73 million.
Considering the fact that the conglomerate employs 155 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 95.68%, operating margin of -322.0%, and the pretax margin is -283.95%.
Tango Therapeutics Inc (TNGX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Tango Therapeutics Inc is 45.31%, while institutional ownership is 56.01%. The most recent insider transaction that took place on Feb 04 ’25, was worth 8,289. In this transaction General Counsel of this company sold 2,774 shares at a rate of $2.99, taking the stock ownership to the 68,570 shares. Before that another transaction happened on Feb 05 ’25, when Company’s General Counsel sold 2,556 for $3.16, making the entire transaction worth $8,081. This insider now owns 66,014 shares in total.
Tango Therapeutics Inc (TNGX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.49% during the next five years compared to 7.47% growth over the previous five years of trading.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Here are Tango Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.20, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Compared to the last year’s volume of 0.77 million, its volume of 1.11 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 10.26%. Additionally, its Average True Range was 0.22.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 1.59%, which indicates a significant decrease from 10.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.53% in the past 14 days, which was lower than the 109.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.84, while its 200-day Moving Average is $6.36. Nevertheless, the first resistance level for the watch stands at $2.14 in the near term. At $2.38, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.54. If the price goes on to break the first support level at $1.74, it is likely to go to the next support level at $1.57. Now, if the price goes above the second support level, the third support stands at $1.33.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
With a market capitalization of 205.40 million, the company has a total of 107,418K Shares Outstanding. Currently, annual sales are 36,530 K while annual income is -101,740 K. The company’s previous quarter sales were 11,610 K while its latest quarter income was -29,170 K.
